NEW YORK, May 16, 2017 -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Lion Biotechnologies, Inc. (NASDAQ:LBIO) who purchased shares between November 14, 2013 and April 10, 2017. The action, which was filed in the United States District Court for the Northern District of California, alleges that the Company violated federal securities laws.
In particular, the complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that (1) through its former CEO Manish Singh, Lion was engaged in a scheme to mislead investors by commissioning over 10 internet publications and 20 widely distributed emails promoting the Company to potential investors that purported to be independent from the company when, in truth, they were paid promotions; (2) Singh engaged a notorious stock promotion firm to pay writers to publish articles about Lion on investment websites, as well as to coordinate the distribution of articles to thousands of electronic mailboxes; (3) Singh actively participated in the promotional work for the Company and understood that the promotion firm was using writers who would not disclose that Lion was indirectly compensating them for their publications; and (4) consequently, defendants’ public statements were materially false and misleading at all relevant times.
Shareholders have until June 13, 2017 to petition the court for lead plaintiff status. Your ability to share in any recovery does not require that you serve as lead plaintiff. You may choose to be an absent class member.
If you suffered a loss during the class period and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit http://www.kleinstocklaw.com/pslra-sa/lion-biotechnologies-inc?wire=3.
Joseph Klein, Esq. is an experienced attorney and has also practiced as a Certified Public Accountant. Mr. Klein represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Joseph Klein, Esq. Empire State Building 350 Fifth Avenue 59th Floor New York, NY 10118 Telephone: (212) 616-4899 Fax: (347) 558-9665 www.kleinstocklaw.com


Alibaba-Backed Moonshot AI Unveils Kimi K2.5 to Challenge China’s AI Rivals
C3.ai in Merger Talks With Automation Anywhere as AI Software Industry Sees Consolidation
China Approves First Import Batch of Nvidia H200 AI Chips Amid Strategic Shift
ANTA Sports to Acquire Major Stake in Puma in €1.5 Billion Deal, Signaling Strategic Revival
Puma’s Historic Rivalry With Adidas Enters a New Era as Anta Deal Signals Turnaround Push
UK Politicians Call for Full Competition Review of Netflix’s Warner Bros Discovery Deal
Micron to Expand Memory Chip Manufacturing Capacity in Singapore Amid Global Shortage
Meta Faces Lawsuit Over Alleged Approval of AI Chatbots Allowing Sexual Interactions With Minors
Zijin Mining Shares Hit Record High on $4 Billion Allied Gold Acquisition
SoftBank Shares Surge as It Eyes Up to $30 Billion New Investment in OpenAI
California Governor Gavin Newsom Launches Review Into Alleged TikTok Content Suppression After U.S. Ownership Deal
Boeing Posts Fourth-Quarter Profit on Jeppesen Sale Despite Ongoing Unit Losses
Woodside Energy Flags Lower 2026 Production Outlook Despite Strong Q4 Revenue Beat
Tesla Loses Ground in Europe as BYD Accelerates EV Market Share in 2025
The Maire - EuroChem Case: Three Lessons for Global Business
LVMH Investors Watch Earnings Closely as Luxury Recovery Faces New Challenges 



